AzTrials
AzTrials

Obsessive-Compulsive DisorderNCT02909660

What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder

A study testing Cognitive-behavioural therapy in people with Obsessive-Compulsive Disorder, run by Concordia University, Montreal at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates the efficacy and acceptability of two cognitive-behavioural interventions for reassurance seeking behaviour in obsessive-compulsive disorder (OCD), a family accommodation reduction protocol vs. a novel support-seeking protocol. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obsessive-Compulsive Disorder
What is being tested?
Cognitive-behavioural therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteCanada
Study dates
Sep 2016to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of OCD
  • Engaging in reassurance seeking more than once a day about the same thing
  • Willingness to allow the experimenter to contact a significant other from whom the participant seeks reassurance regularly
  • Ability to read, write, and communicate in English

Who cannot join

  • Current suicidal ideation/intent
  • Current substance abuse
  • Psychosis
  • Diagnosis of bipolar disorder (I or II)
  • If participants are on medication they must be on a stable dose (i.e., have maintained a consistent dose for at least three months) and agree not to change their medication regimen for the duration of the study

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Concordia University

    Montreal, Quebec, H4B 1R6

Other trials in Canada

About this study

This study evaluates the efficacy and acceptability of two cognitive-behavioural interventions for reassurance seeking behaviour in obsessive-compulsive disorder (OCD), a family accommodation reduction protocol vs. a novel support-seeking protocol. Half of participants will be randomly assigned to participate in the support-seeking intervention, whereas the other half will participate in the family accommodation reduction intervention.

Read the detailed description

An existing family accommodation reduction intervention to reduce reassurance seeking behaviour in OCD (which represents treatment as usual, or TAU) is being compared to a novel support-seeking intervention to determine which is more efficacious and acceptable to participants.

The TAU protocol asks participants to make an agreement with their significant others to withhold reassurance when it is sought. It is believed that this behaviourally-based intervention encourages extinction of reassurance seeking over time by eliminating reinforcement of the behaviour by significant others.

The support-seeking intervention asks participants to move towards adaptively seeking support from a significant other to manage anxiety or distress rather than seeking reassurance. Significant others are taught to provide support rather than reassurance. It is believed that support-seeking may reduce reassurance seeking behaviour because it helps participants manage the anxiety or distress that underlies the requests for reassurance without interfering with disconfirmatory learning.

Being tested
Cognitive-behavioural therapy
Medical subject headings
Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive-behavioural therapyOther

    Empirically-supported psychological intervention for various mental health concerns including obsessive-compulsive disorder (OCD). Includes components to foster cognitive (i.e., thinking) and behavioural changes.

Study groups in NCT02909660
Study groupRoleWhat they receive
Support-seeking interventionExperimentalCognitive-behavioural therapy intervention that guides participants to seek support rather than reassurance; participants' significant others are asked to provide support rather than reassurance.
Receives: Other: Cognitive-behavioural therapy
Family accommodation reduction interventionActive comparatorCognitive-behavioural therapy intervention that guides participants' significant others to withhold reassurance when it is requested; participants are asked to refrain from seeking reassurance.
Receives: Other: Cognitive-behavioural therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported reassurance seeking behaviour

    Number of times participants self-report seeking reassurance per day

    Measured: 5 weeks (baseline through 3 week follow-up)

  2. Self-reported support-seeking behaviour

    Number of times participants in the support-seeking condition self-report seeking reassurance per day

    Measured: 4 weeks (condition assignment through 3 week follow-up)

  3. Self-reported anxiety

    Level of anxiety on average per day, self-rated from 0-100

    Measured: 5 weeks (baseline monitoring through 3 week follow-up)

  4. One-week follow-up: Treatment Acceptability and Adherence Scale (TAAS; Milosevic, Levy, Alcolado, & Radomsky, 2015)

    Validated questionnaire assessing how acceptable participants find an intervention as well as ease of adherence.

    Measured: One-week follow-up

  5. One-week follow-up: Endorsement and Discomfort Scales (EDS; Tarrier, Liversidge, & Gregg, 2006)

    Validated questionnaire assessing acceptability of and discomfort caused by an intervention.

    Measured: One-week follow-up

  6. Three-week follow-up: Treatment Acceptability and Adherence Scale (TAAS; Milosevic, Levy, Alcolado, & Radomsky, 2015)

    Validated questionnaire assessing how acceptable participants find an intervention as well as ease of adherence.

    Measured: Three-week follow-up

  7. Three-week follow-up: Endorsement and Discomfort Scales (EDS; Tarrier, Liversidge, & Gregg, 2006)

    Validated questionnaire assessing acceptability of and discomfort caused by an intervention.

    Measured: Three-week follow-up

Secondary outcomes (2)
  1. Change in self-reported reassurance-seeking

    Pre-post assessment of change in the number of times per day that participants self-report reassurance seeking behaviour from the baseline monitoring week to the follow-up assessments.

    Measured: Baseline to one-week follow-up and baseline to three-week follow-up

  2. Change in anxiety

    Pre-post assessment of change in participants' self-reported anxiety ratings, as rated from 0-100

    Measured: Baseline (monitoring week 1) to end of reassurance provision week (monitoring week 2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionOct 2017
  4. Study completionNov 2017

Why it stopped: Recruitment difficulties / lack of participants

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02909660
Sponsor's protocol ID
30006114
Status last verified
Dec 2017
First submitted
14 Sep 2016
Last updated
12 Dec 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive-behavioural therapy in people with Obsessive-Compulsive Disorder, run by Concordia University, Montreal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 12 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Recruitment difficulties / lack of participants). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported reassurance seeking behaviour (time frame: 5 weeks (baseline through 3 week follow-up)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in